Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Gough, M. J.
  • Crittenden, M. R.
  • Sarff, M.
  • Pang, P.
  • Seung, S. K.
  • Vetto, J. T.
  • Hu, H. M.
  • Redmond, William
  • Holland, J.
  • Weinberg, A. D.

publication date

  • October 2010

journal

  • Journal of Immunotherapy  Journal

subject areas

  • Animals
  • Antibodies, Monoclonal
  • CD8-Positive T-Lymphocytes
  • Cell Line, Tumor
  • Cell Proliferation
  • Chemotherapy, Adjuvant
  • Cytotoxicity, Immunologic
  • Immunotherapy
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neoplasm Recurrence, Local
  • Radiotherapy
  • Receptors, Antigen, T-Cell
  • Receptors, OX40
  • Sarcoma
  • Skin Neoplasms
scroll to property group menus

Research

keywords

  • CD134
  • CD8
  • costimulation
  • radiation
  • surgery
scroll to property group menus

Identity

PubMed Central ID

  • PMC3563298

International Standard Serial Number (ISSN)

  • 1524-9557

Digital Object Identifier (DOI)

  • 10.1097/CJI.0b013e3181ee7095

PubMed ID

  • 20842057
scroll to property group menus

Additional Document Info

start page

  • 798

end page

  • 809

volume

  • 33

issue

  • 8

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support